GSKCONS

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated January 09,2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/gskchl_declaration_120107.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated January 03,2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSK_Dis_12012007.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange as per letter dated January 05, 2007 a copy of annual declaration/ disclosure forms as received from the Directors of the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server.<a href=/content/corporate/GSK_Dis_09012007.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange the Abstract of the terms and conditions of remuneration of Mr. Zubair Ahmed as Managing Director as required to be circulated to the members of the Company under Section 302 of the Companies Act, 1956. The Said Abstarct has been dispatched to the shareholders of the Company on January 2, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/glaxo_remun

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that "Mr. Zubair Ahmed has been appointed as the Managing Director of the Company in Place of Mr. Nicholas J Massey w.e.f. January 1, 2007 under the provisions of Article 97-A of the Articles of Association of the Company and approved by the Board of Directors at its meeting held today (19 Dec 2006) at 1.00 p.m. at the Company's Corporate Office at DLF Plaza Tower, DLF City, Phase- 1, Gurgaon- 122002".

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that "Mr. Zubair Ahmed has been appointed as Vice President & General Manager of the Company with effect from 1 December 2006".

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors in its meeting held on October 26, 2006 has declared an interim dividend of Rs.10/- per equity share for the year ending December 31, 2006.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Company has fixed November 01, 2006 as the "Record Date" for the purpose of payment of interim dividend, if approved at the Board Meeting. Dividend warrants in respect of the proposed dividend, if declared, will be made payable on or before November 23, 2006.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange regarding the article titled "Britannia set for global buys in health foods" in Economic Times on September 01,2006. In this connection the company has clarified as under: "Glaxosmithkline Consumer Healthcare Limited denies any move to divest its Nutritional portfolio and assures all its stakeholders that the reportage is based on conjecture and has no basis in truth whatsoever".

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that Mr. P Dwarakanath will retire as Wholetime Director of the Company w.e.f. July 31, 2006 upon attaining the age of retirement. Mr. P Dwarakanath will however continue as the Non Executive Director on the Board of the Company. This has been taken note of by the Board of Directors at its meeting held on July 27, 2006. The Company has further informed that Mr. Arun Sehgal has been appointed as the Vice President - Human Resources and Administration.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that HDFC Mutual Fund under its schemes has acquired the shares as follows: HDFC Prudence Fund has acquired 200,000 shares aggregating to 0.47% of the total paid up capital of Glaxosmithkline Consumer Healthcare Limited on June 22, 2006. The mode of acquisition is through Market Purchase and the shareholding of HDFC Mutual Fund under its schemes after the said acquisition is 21,63,278 shares aggregating to 5.14% as follows:- 1) HDFC Prudence Fund total shareholding is 6,84,523 shares aggregating to 1.63%; 2) HDFC Long Term E

HDFC Asset Management Company Limited has informed the Exchange that HDFC Mutual Fund under its schemes has acquired the shares as follows: HDFC Prudence Fund has acquired 200,000 shares aggregating to 0.47% of the total paid up capital of Glaxosmithkline Consumer Healthcare Limited on June 22, 2006. The mode of acquisition is through Market Purchase and the shareholding of HDFC Mutual Fund under its schemes after the said acquisition is 21,63,278 shares aggregating to 5.14% as follows:- 1) HDFC Prudence Fund total shareholding is 6,84,523 shares aggregating to 1.63%; 2) HDFC Long Term Equity

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that Mr. Partha S Mukherjee, Wholetime Director, has resigned as Director of the Company w.e.f. April 30,2006. Further, Mr. A S Lakshmanan, Non Executive Director of the Company, will cease to be a Director on reaching the age of retirement w.e.f. June 12,2006. Both the resignations have been accepted by the Board of Directors in their meeting held on April 28,2006.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of the minutes of the proceedings of the AGM of the Members of the Company held on April 29, 2006. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members of the Company shall remain closed from April 20, 2006 to April 28, 2006 (both days inclusive) for taking on record the shareholders for the purpose of the AGM of the equity shareholders scheduled to be held on April 29, 2006.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the equity shares of the Company have been delisted from the Calcutta Stock Exchange as confirmed by the Exchange vide their letter dated February 21, 2006 and the name of the Company has been removed as a listed securities from the Official list of the Exchange.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that Praveen K. Gupta, Director-Operations holds 3 shares of the company as on December 31, 2005.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board at its meeting held on January 24, 2006 have taken note of the appointment of Mr. Praveen K Gupta who has been nominated as Wholetime Director by Horlicks Limited under Article 97-A of the Articles of Association of the Company with effect from January 24, 2006 in place of Mr. David S Allen who ceased to be a Director with effect from January 24, 2006.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration/ disclosure forms as received on January 09, 2006 from the Directors of the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that Mr. Praveen Kumar Gupta has been nominated as Nominee Director of Horlicks Limited, U.K., w.e.f. January 24, 2006 to replace Mr. David S. Allen. This will be placed before the next Board meeting of the Company to give effect to the changes. Further, the Company has appointed Mr. Ramakrishnan Subramanian as Deputy Chief Financial Officer w.e.f. January 11, 2006.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the board in its meeting held on October 21, 2005 has declared an interim dividend of Rs.8.00 per equity share for the year ending December 31, 2005.Dividend warrants in respect of the proposed dividend will be made payable on or before November 18, 2005.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that in pursuance of Regulation 12(1) of the SEBI (Buy-back of Securities) Regulations, 1998, 842 physical share certificates representing 95,918 Equity shares of Rs.10 each of the Company bought back by the Company in response to the Letter of Offer dated March 02, 2005 addressed to all the shareholders of the Company (out of a total of 33,25,083 equity shares bought back by the Company including 32,29,165 equity shares in dematerialised form), were physically destroyed on April 27, 2005. The share capital of the Company st

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of the Minutes of the Proceedings of the AGM of the members of the Company held on April 29, 2005. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members of the Company shall remain closed from April 21, 2005 to April 28, 2005 (both days inclusive) for taking on record the shareholders for the purpose of the AGM of the equity shareholders scheduled to be held on April 29, 2005.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the members of the Company have approved through postal ballot the buy back of equity shares of Rs.10 each at a price not exceeding Rs.370 per equity share and for an amount not exceeding Rs.1,23,02.81 Lacs which constitutes 25% of the Paid up Equity Share Capital and Free Reserves of the Company as on December 31,2003. The details of the results of the postal ballot declared on January 20, 2005 is as follows: a) Total number of valid votes cast - 19259951; b)Votes in favor of the Resolution - 19123351 (99.29%); c) Vote

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Buy-back Committee of Directors of the Company, in their meeting held on January 20, 2005, has decided to fix March 01, 2005 as the 'Specified Date' for the purpose of determining the name of the shareholders to whom the Letter of Offer for buying back the equity shares of the company shall be sent.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange of the annual declaration/disclosure of details of shares held by Directors/Officers/ Employees as on December 31, 2004. The details are as follows: 1) Gautam Chakraborty, Director - Finance and IT holds Nil shares; 2) Ms. Sarmila Chakraborty, wife of Gautam Chakraborty and Ms.Rikhia Chakraborty,Daughter of Gautam Chakraborty, both hold Nil shares.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Buy-back Committee of Directors of the Company, in their meeting held on January 20, 2005, have decided to buy back the equity shares at a price of Rs.370 per equity share.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange of the annual declaration/disclosure of details of shares held by Directors/Officers/ Employees/Dependent Family Members as on December 31, 2004. The details are as follows: 1) P Dwarakanath, Director - HR & Admn. holds Nil shares; 2) Usha Dwarakanath (Wife of P. Dwarakanath) holds Nil shares.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange the annual declaration / disclosure of shares of the company held by Directors/Officers/Employees as on December 31,2004.The details of the same are as follows : 1) Mr. Nicholas John Massey, Managing Director holds Nil shares. 2)Mr. Partha S Mukherjee, Director Legal & Corporate Affairs holds Nil shares and Minoti Mukherjee (Jt.P S Mukherjee) wife holds 646 shares. 3) Mr. David A Allen ,Director Operations holds Nil shares. 4) Mr. A S Lakshmanan, Director holds Nil shares.5)Mr.Subodh Bhargava, who has joined as Director

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that Mr. Arnab Roy Choudhury,holds Nil shares of the company.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the illegal strike resorted to by the temporary workmen at the company's Nabha(Punjab) factory has been called off and production resumed effective December 18,2004.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the temporary workmen of the Company at its factory situated at Patiala Road, Nabha 147201 (Punjab) have resorted to disruption of work amounting to an illegal Strike thereby stopping production completely at the factory. The Company shall keep the Exchanges informed of the situation / developments from time to time.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the BOD's at a meeting held on December 10, 2004 have considered and approved the buy back of the equity shares of the Company upto 33,25,083 fully paid up equity shares of Rs.10/- each, constituting up to 7.33% of the paid-up Equity Share Capital of the Company at a price not exceeding Rs.370/- per equity share and an amount not exceeding Rs.12302.81 Lakhs which constitutes 25% of the Paid up capital and Free Reserves of the Company as on December 31, 2003.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board has, at its meeting held on October 25, 2004, declared a second interim dividend of Rs.3.70 per equity share for the year ending December 31, 2004 and the dividend warrants in respect of the proposed dividend will be made payable on or before November 22, 2004.

Glaxosmithkline Consumer Healthcare Limited had informed the Exchange that the company has fixed October 29, 2004 as the record date for the purposes of payment of second interim dividend, if approved at the Board Meeting to be held on October 25, 2004. The Company has now informed that the Record Date for the purpose of payment of interim dividend, if approved at the Board Meeting, has been changed to November 02, 2004 instead of October 29, 2004.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Equity shares of the Company have been delisted from the following stock exchanges: (1) The Ludhiana Stock Exchange Assn Limited. (2) The Delhi Stock Exchange Assn Limited w.e.f September 2, 2004. (3) The Madras Stock Exchange Assn Limited w.e.f. August 23, 2004.